A Novel Faster-Acting, Dry Powder-Based, Naloxone Intranasal Formulation for Opioid Overdose
Crossref DOI link: https://doi.org/10.1007/s11095-022-03247-5
Published Online: 2022-04-06
Published Print: 2022-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lapidot, Tair https://orcid.org/0000-0003-3229-1212
Bouhajib, Mohammed
Faulknor, Janice
Khan, Shabaz
Krayz, Galia Temtsin
Abrutzky, Carolina
Megiddo, Dalia
Text and Data Mining valid from 2022-04-06
Version of Record valid from 2022-04-06
Article History
Received: 12 December 2021
Accepted: 25 March 2022
First Online: 6 April 2022